Baxter to Divest Vantive Kidney Care to the Carlyle Group for $3.8B
Pending regulatory approval, this transfer to a global investment company will take place in late 2024 or early 2025. Baxter will use the proceeds to pay down debt.
Read the full article » | Posted 08-16-2024
Related Articles
- See AKF’s Care Collaboration at Home Session Posted 10-15-2024
- IV and PD Fluid Shortages Caused by Hurricane Helene Posted 10-15-2024
- Good News: Baxter Bringing Marion, NC Plant Back Up in Stages Posted 10-15-2024
- Watch Our Webinar on Making the Switch from PD to Home HD Posted 10-15-2024